Uncária Tomentosa (Wild.) D.C. in inflammatory processes in Alzheimer's disease

Authors

  • Fernando Campos Barbosa
  • Janaina Drawanz Pereira Rezende
  • Emiliana Junqueira da Silva

Keywords:

Uncaria Tomentosa, Cat´s claw, Alzheimer’ Disease

Abstract

Objective: to explore the mechanisms involved in the triggering and progression of Alzheimer's disease (AD) in order to support the suggestion of the Uncaria Tomentosa (Wild.) plant as another adjuvant therapeutic possibility for the prevention and treatment of AD. Method: This is a narrative review of the literature conducted with a search for articles published on indexed bases and directly in the journals of interest, using as descriptors "Uncária Tomentosa", "Alzheimer's disease", and the respective terms in English. Results: with advances to understand the molecular mechanisms that trigger the effects presented in the development of AD, the various mechanisms of phytocompounds present in the plant suggest its use as neuroprotector, by anti-inflammatory, immunomodulatory and antioxidant mechanisms, whose evidence in the literature is presented to defend its use in this pathology. Conclusion: evidence was found to suggest the inclusion of Uncaria tomentosa (Wild.) as a possible complementary therapy in the treatment of AD. Its use should be better explored for application as a complementary treatment to conventional therapies for AD..

References

Sereniki AV, Frazão MAB. A doença de Alzheimer: aspectos fisiopatológicos e farmacológicos. Revista de Psiquiatria do Rio Grande do Sul, 30(1):1-17, 2008.

Smeltzer SC, Bare BG. As demências: demência por infarto e por Doença de Alzheimer. In: Smeltzer, S. C.; Bare, B. G. Tratado de enfermagem médico cirúrgica. 10.ed. Rio de Janeiro: Guanabara Koogan; 2006. p. 218-225.

Machado JCB. Doença de Alzheimer. In: Freitas EV, Py L, Neri AL, Cançado FAX, Gorzoni ML, Rocha SM. Tratado de geriatria e gerontologia. Rio de Janeiro: Editora Guanabara Koogan; 2002. p. 133-47.

Nitrini R, Bottino CMC, Albala C, Capuñay NSC, Ketzoian C, Rodriguez JJL, Maestre GE, Ramos-Cerqueira AT, Caramelli P. Prevalence of dementia in Latin America: a collaborative study of population-based cohorts. International Psychogeriatrics; 21: 622-630, 2009.

Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci.; 2:12, 2010.

Feter N, Leite JS, Caputo EL, Cardoso RK, Rombaldi AJ. Who are the people with Alzheimer's disease in Brazil? Findings from the Brazilian Longitudinal Study of Aging. Rev Bras Epidemiol.; 24:e210018, 2021.

Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid Med Cell Longev.; 2017:8416763, 2017.

Poljsak B. Strategies for reducing or preventing the generation of oxidative stress. Oxid Med Cell Longev.; 2011:194586, 2011.

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet.; 396(10248):413-446, 2020.

John OO, Amarachi IS, Chinazom AP, Adaeze E, Kale MB, Umare MD, Upaganlawar AB. Phytotherapy: A promising approach for the treatment of Alzheimer's disease.Pharmacological Research - Modern Chinese Medicine; 2:100030, 2022.

Gregory J, Vengalasetti YV, Bredesen DE, Rao RV. Neuroprotective Herbs for the Management of Alzheimer's Disease. Biomolecules; 11(4):543, 2021.

Cummings JL. Treatment of Alzheimer’s disease: current and future therapeutic approaches. Rev. Neurol. Dis.; 1(2): 60-69, 2004.

Goedert M, Spillantini M.G. A century of Alzheimer’s disease. Science; 314: 777-781, 2006.

Racchi M, Mazzucchelli M, Porrello E, Lanni C, Govoni S. Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacol. Res.; 50(4): 441–451, 2004.

Ge M, Zhang J, Chen S, Huang Y, Chen W, He L, Zhang Y. Role of Calcium Homeostasis in Alzheimer's Disease. Neuropsychiatr Dis Treat.; 18:487-498, 2022.

Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer's disease. Alzheimers Dement (N Y); 4:575-590, 2018.

Czapski GA, Strosznajder JB. Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer's Disease. Int J Mol Sci.; 22(21):11677, 2021.

Moheet A, Mangia S, Seaquist ER. Impact of diabetes on cognitive function and brain structure: impact of diabetes on brain. Ann. N.Y. Acad. Sci.; 1353: 60-71, 2015.

Komleva Y, Chernykh A, Lopatina O, Gorina Y, Lokteva I, Salmina A, Gollasch M. Inflamm-Aging and Brain Insulin Resistance: New Insights and Role of Life-style Strategies on Cognitive and Social Determinants in Aging and Neurodegeneration. Front Neurosci.; 14:618395, 2021.

Maynard S, Fang EF, Scheibye-Knudsen M, Croteau DL, Bohr VA. DNA Damage, DNA Repair, Aging, and Neurodegeneration. Cold Spring Harb Perspect Med.; 5(10): a025130, 2015.

Cenini G, Lloret A, Cascella R. Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View. Oxid Med Cell Longev.; 9;2019:2105607, 2019.

Ionescu-Tucker A, Cotman CW. Emerging roles of oxidative stress in brain aging and Alzheimer's disease. Neurobiol Aging.; 107:86-95, 2021.

Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front Aging Neurosci.; 2:12, 2010.

Sellal F, Nieoullon A, Michel G, Michel BF, Lacomblez L, Geerts H, Delini Stula A, Bordet R, Bentué-Ferrer D, Allain H: Pharmacology of Alzheimer’s Disease: Appraisal and Prospects. Dement. Geriatr. Cogn. Disord.; 19: 229-245, 2005.

Caricati-Neto A, Abech D’Angelo LC, Reuter H, Jurkiewicz NH, Garcia AG, Jurkiewicz A. Enhancement of purinergic neurotransmission by galantamine and other acetylcholinesterase inhibitors in the rat vas deferens. Eur. J. Pharmacol.; 503(1-3): 191-201, 2004.

Farlow MR, Cummings JL. Effective Pharmacologic Management of Alzheimer’s Disease. The American Journal of Medicine; 20(5): 388-397, 2007.

Thomas SJ, Grossberg GT. Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias. Clin. Interv. Aging; 4: 367-77, 2009.

Arias E, Alés E, Gabilan NH, Cano-Abad MF, Villarroya M, García AG, López MG. Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacol.; 46(1): 103-114, 2004.

Lorrio S, Sobrado M, Arias E, Roda JM, Garcia AG, Lopez MG. Galantamine post ischemia provides neuroprotection and memory recovery against transient global cerebral ischemia in gerbils. J. Pharmacol. Exp. Ther.; 322(2): 591–599, 2007.

Inestrosa NC, Álvarez A, Pérez CA, Moreno RD, Vicente M, Linker C, Casanueva OI, Soto C, Garrido J. Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer’s fibrils: possible role of the peripheral site of the enzyme. Neuron; 16(4): 881–891, 1996.

Huang LK, Chao SP, Hu CJ. Clinical trials of new drugs for Alzheimer disease. J Biomed Sci.;27(1):18, 2020.

Pereira JD, Caricati-Neto A, Miranda-Ferreira R, Smaili SS, Godinho RO, de los Rios C, Léon R, Villaroya M, Samadi A, Marco-Contelles J, Jurkiewicz NH, Garcia AG, Jurkiewicz A. Effects of novel tacripyrines ITH12117 and ITH12118 on rat vas deferens contractions, calcium transients and cholinesterase activity. Eur J Pharmacol.; 660(2-3):411-9, 2011.

Cabieses F. The Saga of the Cat’s Claw. Via Lactera Editores, Lima 1994.

Kemper KJ. Cat’s Claw (Uncaria tomentosa). Longwood Herbal Task Force; 1-13, 1999.

Taylor L. Herbal Secrets of the Rainforests. 2nd ed. Sage Press, Inc., Austin, TX, USA 2002.

Reis SRIN, Valente LMM, Sampaio AL, Siani AC, Gandini M, Azeredo EL, D’Avila LA, Mazzei JL, Henriques MD, Kubelka CF. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus‐2. International Immunopharmacolology; 8: 468-476, 2008.

Santos Araújo MdoC, Farias IL, Gutierres J, Dalmora SL, Flores N, Farias J, de Cruz I, Chiesa J, Morsch VM, Chitolina Schetinger MR. Uncaria tomentosa-Adjuvant Treatment for Breast Cancer: Clinical Trial. Evid Based Complement Alternat Med.; 2012:676984, 2012.

Valerio LG Jr, Gonzales GF. Toxicological Aspects of the South American Herbs Cat’s Claw (Uncaria tomentosa) and Maca (Lepidium meyenii). A Critical synopsis. Toxicol. Rev.; 24(1):11-35, 2005.

Yepes-Pérez AF, Herrera-Calderon O, Quintero-Saumeth J. Uncaria tomentosa (cat's claw): a promising herbal medicine against SARS-CoV-2/ACE-2 junction and SARS-CoV-2 spike protein based on molecular modeling. J Biomol Struct Dyn.;40(5):2227-2243, 2022.

Farias IL, Araújo MC, Farias JG, Rossato LV, Elsenbach LI, Dalmora SL, Flores NM, Durigon M, Cruz IB, Morsch VM, Schetinger MR. Uncaria tomentosa for Reducing Side Effects Caused by Chemotherapy in CRC Patients: Clinical Trial. Evid Based Complement Alternat Med.; 2012:892182, 2012.

Reis SRIN, Valente LMM, Sampaio AL, Siani AC, Gandini M, Azeredo EL, Kubelka CF. Immunomodulating and antiviral activities of Uncaria tomentosa on human monocytes infected with Dengue Virus-2. International Immunopharmacology; 8(3): 468–476, 2008.

Gonzales GF, Valerio LG Jr. Medicinal Plants from Peru: A Review of Plants as Potential Agents Against Cancer. Anticancer Agents Med.; Chem. 6(5):429-444, 2006.

Batiha GE-S, Magdy Beshbishy A, Wasef L, Elewa YHA, Abd El-Hack ME, Taha AE, Al-Sagheer AA, Devkota HP, Tufarelli V. Uncaria tomentosa (Willd. ex Schult.) DC.: A Review on Chemical Constituents and Biological Activities. Applied Sciences.; 10(8):2668, 2020.

Ramirez E. Curso introducción a la etnobotânica. Lima: Universidad Cayetano Heredia Faculdad de Ciencias y Filosofia, 1992. 10 p.

Gonçalves C, Dinis T, Batista MT. Antioxidant properties of proanthocyanidins of Uncaria tomentosa bark decoction: a mechanism for anti‐inflammatory activity.Phytochemistry; 66(1): 89-98, 2005.

Simões ERB, Machado RR, Pessoa CDO, Marques LGA. O potencial fitoterapêutico da Uncaria tomentosa (Willd.) DC. Rubiaceae: monitoramento científico e tecnológico. Revista Fitos; 16(Supl.2): 193-205, 2022.

Winkler C, Wirleitner B, Schoeroecksnadel K, Schennach H, Mur E, Fuchs D. In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells. Planta Medica; 70(3): 205-210, 2004.

Wilson SD, Mundson AE, Meade BJ. Assessment of the functional integrity of the humoral immune response: The plaque-forming cell assay and the enzyme-linked immunosorbent assay. Methods: A Companion to Methods in Enzymology; 19: 3-7, 1999.

Keplinger K, Laus G, Wurm M, Dierich MP, Teppner H. Uncaria tomentosa (Willd.) DC. - Ethnomedicinal use and new pharmacological, toxicological and botanical results. Journal of Ethnopharmacology; 64(1): 23-24, 1999.

Lemaire I, Assinnewe V, Cano P, Awang DVC, Arnason JT. Stimulation of interleukin‐1 and 6 production in alveolar macrophages by the neotropical liana Uncaria tomentosa (Uña de Gato). Journal of Ethnopharmacology; 64(2): 109- 115, 1999.

Sandoval M, Okuhama NN, Zhang XJ, Condezo LA, Lao J, Angeles FM, Musah RA, Miller MJS. Anti-inflammatory and antioxidant activities of cat’s claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine; 9(4): 325-337, 2002.

Cerri R. New quinóvico acid glycosides from Uncaria tomentosa. Journal of Natural Products; 51(2) 257-261, 1988.

Williams JE. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Alternative Medicine Review; 6(6): 567-579, 2001.

Desmachelier C, Mongelli E, Coussio J, Ciccia G. Evaluation of the in vitro antioxidant activity in extracts of Uncaria tomentosa (Willd.) DC. Phytotherapy Research; 11(3): 254-256, 1997.

Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh Fokou PV, Azzini E, Peluso I, Prakash Mishra A, Nigam M, El Rayess Y, Beyrouthy ME, Polito L, Iriti M, Martins N, Martorell M, Docea AO, Setzer WN, Calina D, Cho WC, Sharifi-Rad J. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front Physiol.; 11:694, 2020.

Caballero M, Arsenak M, Abad MJ, I.M. C, Taylor P. Effect of plant extracts on B16-BL6 melanoma cell growth and metastasis in C57BL/6 mice. Acta Cient Venez; 55(7-8): 21-27, 2005.

Fazio AL, Ballén D, Cesari IM, Abad MJ, Miriam A, Peter T. An ethanolic extract of Uncaria tomentosa reduces inflammation and B16-BL6 melanoma growth in C57BL/6 mice. Bol. Latinoam. Caribe Plant. Med. Aromaticas; 7(4): 217-224, 2008.

Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov.; 20(9):689-709, 2021.

Akesson C, Lindgren H, Pero RW, Leanderson T, Ivars F. An extract of Uncaria tomentosa inhibiting cell division and NF-kappa B activity without inducing cell death. Int Immunopharmacol.; 3(13-14):1889-900, 2003.

Snow AD, Castillo GM, Nguyen BP et al. The Amazon rain forest plant Uncaria tomentosa (cat’s claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles. Sci Rep; 9: 561, 2019.

Allen-Hall L, Arnason JT, Cano P, Lafrenie RM. Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol.;127(3):685-93, 2010.

Gama CRB, Passos MDL, Varella R, Lasmar R, Gama GF, Oliveira L, JGL Daher, Passos MRL, Geller M. Avaliação clínica da uncaria tomentosa no tratamento e controle de lesões decorrentes de Infecção pelo vírus herpes simplex / Clinical evaluation of uncaria tomentosa in the treatment and control of lesions caused by herpes simplex infection. DST - Jornal Brasileiro de Doenças Sexualmente Transmissiveis; 22(4): 215-221, 2010.

Snow AD, Cummings JA, Tanzi RE et al. In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss. Sci Rep; 11: 3001, 2021.

Gregory J, Vengalasetti YV, Bredesen DE, Rao RV. Neuroprotective Herbs for the Management of Alzheimer's Disease. Biomolecules; 11(4):543, 2021.

Quinn J, Kaye J, Montine T, Robert Stackman R. Phytochemicals in Alzheimer Disease: The Development of Clinical Trials, Pharmaceutical Biology; 42(sup1): 64-73, 2004.

Solomon TM, Leech J, deBros GB, Murphy CA, Budson AE, Vassey EA, Solomon PR. A randomized, double-blind, placebo controlled, parallel group, efficacy study of alpha BRAIN® administered orally. Human Psychopharm. Clinical & Exp.; 31:135–143, 2015.

Downloads

Published

2023-01-20

How to Cite

Barbosa, F. C., Rezende, J. D. P., & Silva, E. J. da. (2023). Uncária Tomentosa (Wild.) D.C. in inflammatory processes in Alzheimer’s disease. Revista De Divulgação Científica Sena Aires, 12(1), 93–111. Retrieved from https://rdcsa.emnuvens.com.br/revista/article/view/207

Issue

Vol. 12 No. 1 (2023): REVISA

Section

Literature Review

License

Copyright (c) 2024 Revista de Divulgação Científica Sena Aires

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

  • Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.

  • Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.